Acute D₂/D₃ Dopaminergic Agonism but Chronic D₂/D₃ Antagonism Prevents NMDA Antagonist Neurotoxicity

Keyphrases

• Neurotoxicity 100%
• Antagonism 100%
• N-methyl-D-aspartate Receptor Antagonist 100%
• D2-D3 100%
• Agonism 100%
• NMDA Receptor Hypofunction 71%
• Pathophysiology 28%
• Daily Dose 28%
• Haloperidol 28%
• Psychosis 28%
• Psychotic Disorders 28%
• Rodents 14%
• Protective Effect 14%
• N-methyl-D-aspartate Receptor (NMDAR) 14%
• Antipsychotics 14%
• Chronic Exposure 14%
• Acute Exposure 14%
• Hypofunction 14%
• Dopamine Agonist 14%
• Complex Circuit 14%
• Transmitter System 14%
• D3 Receptor 14%
• Cognitive Disturbances 14%
• N-methyl-D-aspartate Glutamate Receptor 14%
• Daily Exposure 14%

Neuroscience

• Dopaminergic 100%
• Neurotoxicity 100%
• Aspartic Acid 100%
• NMDA Receptor 71%
• Agonist 28%
• Psychosis 28%
• Dopamine Agonist 28%
• Receptor 28%
• Haloperidol 28%
• Glutamate Receptor 14%
• Antipsychotic 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Dopamine Receptor Stimulating Agent 100%
• Neurotoxicity 100%
• Aspartic Acid 100%
• N Methyl Dextro Aspartic Acid Receptor 71%
• Receptor 28%
• Pathophysiology 28%
• 4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol 28%
• Psychosis 28%
• Long Term Exposure 14%
• Glutamate Receptor 14%
• Antipsychotic 14%
• Dopamine 3 Receptor Stimulating Agent 14%